UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in MDXG — Mimedx Group, Inc.
CIK 861177
NEW YORK, NY
Position in MDXG
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$830,813
-$292,673 QoQ
Shares Held
210,333
+26.7% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 33.349973613270386.ToString("F0")%
Shared 0.ToString("F0")%
None 66.6500263867296.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. MDXG ranks #131 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in MDXG
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $830,813 | 210,333 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,123,486 | 165,951 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,229,134 | 176,094 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,959,854 | 320,762 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,598,947 | 210,388 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,759,217 | 182,871 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,159,801 | 196,244 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,590,328 | 229,485 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,018,154 | 132,228 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $789,166 | 89,985 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $592,347 | 81,255 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $264,808 | 40,062 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $136,609 | 40,062 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $157,363 | 54,831 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $190,261 | 54,831 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $188,691 | 40,062 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $241,973 | 40,062 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $221,298 | 36,518 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $445,618 | 35,621 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||